Annual Accounts Payable
$1.58 M
-$93.00 K-5.54%
31 December 2023
Summary:
Armata Pharmaceuticals annual accounts payable is currently $1.58 million, with the most recent change of -$93.00 thousand (-5.54%) on 31 December 2023. During the last 3 years, it has risen by +$629.00 thousand (+65.79%). ARMP annual accounts payable is now -60.38% below its all-time high of $4.00 million, reached on 31 December 2000.ARMP Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$1.81 M
+$72.00 K+4.13%
30 September 2024
Summary:
Armata Pharmaceuticals quarterly accounts payable is currently $1.81 million, with the most recent change of +$72.00 thousand (+4.13%) on 30 September 2024. Over the past year, it has dropped by -$1.96 million (-51.88%). ARMP quarterly accounts payable is now -57.46% below its all-time high of $4.27 million, reached on 30 September 2000.ARMP Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARMP Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.5% | -51.9% |
| 3 y3 years | +65.8% | - |
| 5 y5 years | +117.4% | - |
ARMP Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -5.5% | +65.8% | -51.9% | +59.5% |
| 5 y | 5 years | -5.5% | +189.8% | -51.9% | +231.8% |
| alltime | all time | -60.4% | +189.8% | -57.5% | +353.8% |
Armata Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.81 M(+4.1%) |
| June 2024 | - | $1.74 M(-15.3%) |
| Mar 2024 | - | $2.06 M(+29.8%) |
| Dec 2023 | $1.58 M(-5.5%) | $1.58 M(-58.0%) |
| Sept 2023 | - | $3.77 M(+124.8%) |
| Dec 2022 | $1.68 M(+47.5%) | $1.68 M(+47.5%) |
| Dec 2021 | $1.14 M(+19.0%) | $1.14 M(+19.0%) |
| Dec 2020 | $956.00 K(+74.8%) | $956.00 K(+74.8%) |
| Dec 2019 | $547.00 K(-25.0%) | $547.00 K(-25.0%) |
| Dec 2018 | $729.00 K(+26.1%) | $729.00 K(+2.1%) |
| Sept 2018 | - | $714.00 K(+4.7%) |
| June 2018 | - | $682.00 K(-15.8%) |
| Mar 2018 | - | $810.00 K(+40.1%) |
| Dec 2017 | $578.00 K(-45.3%) | $578.00 K(-39.1%) |
| Sept 2017 | - | $949.00 K(-48.9%) |
| June 2017 | - | $1.86 M(+67.4%) |
| Mar 2017 | - | $1.11 M(+5.0%) |
| Dec 2016 | $1.06 M(+1.1%) | $1.06 M(-51.4%) |
| Sept 2016 | - | $2.17 M(-2.9%) |
| June 2016 | - | $2.24 M(+11.8%) |
| Mar 2016 | - | $2.00 M(+91.9%) |
| Dec 2015 | $1.04 M(-10.5%) | $1.04 M(-9.5%) |
| Sept 2015 | - | $1.15 M(-15.5%) |
| June 2015 | - | $1.36 M(-11.8%) |
| Mar 2015 | - | $1.55 M(+32.6%) |
| Dec 2014 | $1.17 M(-39.8%) | $1.17 M(-45.6%) |
| Dec 2012 | $1.94 M(-10.4%) | - |
| Sept 2008 | - | $2.14 M(-24.6%) |
| June 2008 | - | $2.84 M(+23.3%) |
| Mar 2008 | - | $2.31 M(+6.8%) |
| Dec 2007 | $2.16 M(+13.7%) | $2.16 M(+5.0%) |
| Sept 2007 | - | $2.06 M(-48.6%) |
| June 2007 | - | $4.00 M(+81.0%) |
| Mar 2007 | - | $2.21 M(+16.4%) |
| Dec 2006 | $1.90 M(+7.4%) | $1.90 M(+0.3%) |
| Sept 2006 | - | $1.90 M(-12.8%) |
| June 2006 | - | $2.17 M(+18.1%) |
| Mar 2006 | - | $1.84 M(+4.0%) |
| Dec 2005 | $1.77 M(+23.3%) | $1.77 M(-5.9%) |
| Sept 2005 | - | $1.88 M(-23.7%) |
| June 2005 | - | $2.46 M(+11.1%) |
| Mar 2005 | - | $2.22 M(+54.4%) |
| Dec 2004 | $1.44 M | $1.44 M(-21.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2004 | - | $1.83 M(-7.8%) |
| June 2004 | - | $1.99 M(+35.8%) |
| Mar 2004 | - | $1.46 M(+15.2%) |
| Dec 2003 | $1.27 M(-36.8%) | $1.27 M(-2.3%) |
| Sept 2003 | - | $1.30 M(-30.6%) |
| June 2003 | - | $1.88 M(-3.2%) |
| Mar 2003 | - | $1.94 M(-3.8%) |
| Dec 2002 | $2.01 M(-41.7%) | $2.01 M(-31.6%) |
| Sept 2002 | - | $2.94 M(-6.0%) |
| June 2002 | - | $3.13 M(-1.1%) |
| Mar 2002 | - | $3.17 M(-8.3%) |
| Dec 2001 | $3.45 M(-13.7%) | $3.45 M(+68.5%) |
| Sept 2001 | - | $2.05 M(+16.0%) |
| June 2001 | - | $1.77 M(-54.5%) |
| Mar 2001 | - | $3.88 M(-3.1%) |
| Dec 2000 | $4.00 M(+73.9%) | $4.00 M(-6.2%) |
| Sept 2000 | - | $4.27 M(+87.5%) |
| June 2000 | - | $2.28 M(+22.9%) |
| Mar 2000 | - | $1.85 M(-19.5%) |
| Dec 1999 | $2.30 M(+35.3%) | $2.30 M(+35.3%) |
| Sept 1999 | - | $1.70 M(+6.3%) |
| June 1999 | - | $1.60 M(+14.3%) |
| Mar 1999 | - | $1.40 M(-17.6%) |
| Dec 1998 | $1.70 M(+21.4%) | $1.70 M(+21.4%) |
| Sept 1998 | - | $1.40 M(-6.7%) |
| June 1998 | - | $1.50 M(-16.7%) |
| Mar 1998 | - | $1.80 M(+28.6%) |
| Dec 1997 | $1.40 M(-26.3%) | $1.40 M(0.0%) |
| Sept 1997 | - | $1.40 M(+7.7%) |
| June 1997 | - | $1.30 M(-7.1%) |
| Mar 1997 | - | $1.40 M(-26.3%) |
| Dec 1996 | $1.90 M(+216.7%) | $1.90 M(+18.8%) |
| Sept 1996 | - | $1.60 M(-36.0%) |
| June 1996 | - | $2.50 M(+525.0%) |
| Mar 1996 | - | $400.00 K(-33.3%) |
| Dec 1995 | $600.00 K(-14.3%) | $600.00 K(+50.0%) |
| Sept 1995 | - | $400.00 K(-20.0%) |
| June 1995 | - | $500.00 K(0.0%) |
| Mar 1995 | - | $500.00 K(-28.6%) |
| Dec 1994 | $700.00 K(+16.7%) | $700.00 K(0.0%) |
| Sept 1994 | - | $700.00 K(-12.5%) |
| June 1994 | - | $800.00 K(+33.3%) |
| Dec 1993 | $600.00 K | $600.00 K |
FAQ
- What is Armata Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals annual accounts payable year-on-year change?
- What is Armata Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals quarterly accounts payable year-on-year change?
What is Armata Pharmaceuticals annual accounts payable?
The current annual accounts payable of ARMP is $1.58 M
What is the all time high annual accounts payable for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high annual accounts payable is $4.00 M
What is Armata Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, ARMP annual accounts payable has changed by -$93.00 K (-5.54%)
What is Armata Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of ARMP is $1.81 M
What is the all time high quarterly accounts payable for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high quarterly accounts payable is $4.27 M
What is Armata Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, ARMP quarterly accounts payable has changed by -$1.96 M (-51.88%)